Mahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program
Mahana IBS recognized as a digital solution with high potential to meet London’s NHS and social care challenges LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Mahana Therapeutics, a leading developer of prescription digital therapeutics designed to empower people living with chronic health conditions, today announced that Mahana has been selected for the DigitalHealth.London’s…